Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.36 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1255656 | 1.00 | CYP2D6 (0.48) | CYP2D6KCNH2ALDH1A1MAPTCYP2C9 | |
| SCHEMBL1255653 | 0.81 | CYP2D6 (0.67) | CYP2D6KCNH2 | |
| SCHEMBL1255657 | 0.81 | CYP2D6 (0.67) | CYP2D6KCNH2 | |
| SCHEMBL1258234 | 0.78 | CYP2D6 (0.44) | CYP2D6KCNH2 | |
| SCHEMBL1257663 | 0.75 | CYP2D6 (0.54) | CYP2D6KCNH2 | |
| SCHEMBL1257662 | 0.75 | CYP2D6 (0.54) | CYP2D6KCNH2 | |
| SCHEMBL640291 | 0.75 | MMP1 (0.57) | CYP2D6KCNH2 | |
| SCHEMBL641490 | 0.75 | MMP1 (0.48) | CYP2D6KCNH2 | |
| SCHEMBL1258308 | 0.74 | CYP2D6 (0.53) | CYP2D6KCNH2 | |
| SCHEMBL1257774 | 0.72 | CYP2D6 (0.47) | CYP2D6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009008905-A1 | HYDROXAMIC ACID DERIVATIVES OF PHENOXY-ACETIC ACIDS AND ANALOGS USEFUL AS THERAPEUTIC AGENTS FOR TREATING ANTHRAX POISONING | PANTHERA BIOPHARMA, LLC. | 2009-01-15 | — | — | WO | disclosed |